Episode
Acute Myeloid Leukemia — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition
- Podcast
- Hematologic Oncology Update
- Published
- Jan 3, 2026
- Duration seconds
- 7053
- Processing state
not_requested- Canonical source
- https://hematologic-oncology.captivate.fm/episode/5596-ashaml25
Actions
POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/acute-myeloid-leukemia-proceedings-from-a-symposium-series-preceding-the-67th-ash-annual-meeting-and-exposition/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/hematologic-oncology-update-916423/acute-myeloid-leukemia-proceedings-from-a-symposium-series-preceding-the-67th-ash-annual-meeting-and-exposition.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr Harry Paul Erba from the Duke Cancer Institute, Dr Amir Fathi from Massachusetts General Hospital, Dr Tara L Lin from The University of Kansas Medical Center, Dr Alexander Perl from the University of Pennsylvania’s Abramson Cancer Center and Dr Eytan M Stein from Memorial Sloan Kettering Cancer Center discuss recent data surrounding the management of AML and their perspectives on clinical application. CME information and select publications here .